Top Markets
Coin of the day
BerGenBio ASA BerGenBio ASA

BerGenBio ASA

BGBIO
Classement en actions #37880
BerGenBio ASA is a biopharmaceutical firm in the clinical development stage,... BerGenBio ASA is a biopharmaceutical firm in the clinical development stage, focused on developing therapies for drug-resistant, immune-evasive, and metastatic cancers, in addition to respiratory conditions. Its leading compound, Bemcentinib, is a bio-available small molecule AXL inhibitor currently in Phase II clinical trials for major cancer indications and COVID-19. The Phase II trial program specifically addresses non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Moreover, the company is progressing tilvestamab, an anti-AXL antibody, through Phase Ib clinical trials. BerGenBio ASA also maintains a collaboration agreement with Merck & Co. for its clinical studies. The company was founded in 2007 and operates from its base in Bergen, Norway.
Prix de l'action
$0.051239
Dernière synchronisation: 2025-11-24
Capitalisation boursière
$1.38M
Changement (1 jour)
-4.48%
Changement (1 an)
-54.57%
Pays
NO
Échange BerGenBio ASA (BGBIO)

Catégorie

Historique des divisions d’actions pour BerGenBio ASA (BGBIO)
L’action BerGenBio ASA (symbole : BGBIO) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 15, 2026.
Une action BGBIO achetée avant le Aug 15, 2026 équivaudrait aujourd’hui à 0 actions BGBIO.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE